78 related articles for article (PubMed ID: 15755060)
1. [Wilms tumor gene (WT1) expression in blood cells from patients with myelodysplastic syndrome].
Abdulkadyrov KM; Gritsaev SV; Kapustin SI; Martynkevich IS; Blinov MN; Bessmel'tsev SS; Tiranova SA; Rugal' VI
Vopr Onkol; 2004; 50(6):668-71. PubMed ID: 15755060
[No Abstract] [Full Text] [Related]
2. Wilms tumor gene WT1 as a tumor marker for leukemic blast cells and its role in leukemogenesis.
Sugiyama H
Methods Mol Med; 2002; 68():223-37. PubMed ID: 11901505
[No Abstract] [Full Text] [Related]
3. Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia.
Hämäläinen MM; Kairisto V; Juvonen V; Johansson J; Aurén J; Kohonen K; Remes K; Salmi TT; Helenius H; Pelliniemi TT
Eur J Haematol; 2008 Mar; 80(3):201-7. PubMed ID: 18081724
[TBL] [Abstract][Full Text] [Related]
4. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of Wilms tumor gene (WT1) mRNA expression in soft tissue sarcoma.
Sotobori T; Ueda T; Oji Y; Naka N; Araki N; Myoui A; Sugiyama H; Yoshikawa H
Cancer; 2006 May; 106(10):2233-40. PubMed ID: 16607650
[TBL] [Abstract][Full Text] [Related]
6. Wilms' tumor 1 (WT1) gene in hematopoiesis: a surrogate marker of cell proliferation as a possible mechanism of action?
Olszewski M; Huang W; Chou PM; Duerst R; Kletzel M
Cytotherapy; 2005; 7(1):57-61. PubMed ID: 16040384
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of WT1 gene isoform transfection on proliferation of leukemia cell line NB4].
Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
Ai Zheng; 2006 Feb; 25(2):163-9. PubMed ID: 16480579
[TBL] [Abstract][Full Text] [Related]
8. Cancer immunotherapy targeting Wilms' tumor gene WT1 product.
Sugiyama H
Expert Rev Vaccines; 2005 Aug; 4(4):503-12. PubMed ID: 16117707
[TBL] [Abstract][Full Text] [Related]
9. The Simultaneous Elevation of Oxidative Stress Markers and Wilms' Tumor 1 Gene during the Progression of Myelodysplastic Syndrome.
Shimizu N; Hasunuma H; Watanabe Y; Matsuzawa Y; Iwashita Y; Tatsuno I; Yokota H
Intern Med; 2016; 55(24):3661-3664. PubMed ID: 27980269
[TBL] [Abstract][Full Text] [Related]
10. Wilms tumor 1 expression: addressing the 'elephant' in MDS.
Madanat YF; Sekeres MA
Leuk Lymphoma; 2019 Mar; 60(3):566-567. PubMed ID: 30714447
[No Abstract] [Full Text] [Related]
11. Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia.
Iwasaki T; Sugisaki C; Nagata K; Takagi K; Takagi A; Kojima T; Ito M; Nakamura S; Naoe T; Murate T
Pathol Int; 2007 Oct; 57(10):645-51. PubMed ID: 17803653
[TBL] [Abstract][Full Text] [Related]
12. Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors.
Tatsumi N; Oji Y; Tsuji N; Tsuda A; Higashio M; Aoyagi S; Fukuda I; Ito K; Nakamura J; Takashima S; Kitamura Y; Miyai S; Jomgeow T; Li Z; Shirakata T; Nishida S; Tsuboi A; Oka Y; Sugiyama H
Int J Oncol; 2008 Mar; 32(3):701-11. PubMed ID: 18292948
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome.
Qian J; Chen Z; Wang W; Cen J; Xue Y
Oncol Rep; 2005 Nov; 14(5):1189-97. PubMed ID: 16211284
[TBL] [Abstract][Full Text] [Related]
14. Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy.
Cilloni D; Messa F; Arruga F; Defilippi I; Gottardi E; Fava M; Carturan S; Catalano R; Bracco E; Messa E; Nicoli P; Diverio D; Sanz MA; Martinelli G; Lo-Coco F; Saglio G
Haematologica; 2008 Jun; 93(6):921-4. PubMed ID: 18443273
[TBL] [Abstract][Full Text] [Related]
15. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
Glienke W; Maute L; Wicht J; Bergmann L
Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis.
Sera T; Hiasa Y; Mashiba T; Tokumoto Y; Hirooka M; Konishi I; Matsuura B; Michitaka K; Udaka K; Onji M
Eur J Cancer; 2008 Mar; 44(4):600-8. PubMed ID: 18255279
[TBL] [Abstract][Full Text] [Related]
17. Wilms' tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome.
Busse A; Gökbuget N; Siehl JM; Hoelzer D; Schwartz S; Rietz A; Thiel E; Keilholz U
Ann Hematol; 2009 Dec; 88(12):1199-205. PubMed ID: 19404640
[TBL] [Abstract][Full Text] [Related]
18. Abnormal stromal cells in myelodysplastic syndromes: genomics presents further evidence.
Mayani H
Leuk Res; 2007 May; 31(5):577-8. PubMed ID: 17113149
[No Abstract] [Full Text] [Related]
19. Curcumin inhibits WT1 gene expression in human leukemic K562 cells.
Anuchapreeda S; Thanarattanakorn P; Sittipreechacharn S; Chanarat P; Limtrakul P
Acta Pharmacol Sin; 2006 Mar; 27(3):360-6. PubMed ID: 16490174
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia.
Rodrigues PC; Oliveira SN; Viana MB; Matsuda EI; Nowill AE; Brandalise SR; Yunes JA
Pediatr Blood Cancer; 2007 Aug; 49(2):133-8. PubMed ID: 16883592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
